StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) income statement

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.67−0.19 (-6.82%)

Close on Nov 18, 2026Market cap $107.60MP/E –Yield –

See a number that looks wrong?